Human microbiota: A crucial gatekeeper in lung cancer initiation, progression, and treatment
Lung cancer is becoming one of the most detrimental cancers with the highest morbidity and mortality rate of all cancers, posing a significant burden for the global health system. Nonetheless, the therapeutic efficacy of traditional lung cancer therapies still remains relatively unsatisfying with va...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Series: | Medicine in Microecology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590097822000052 |
| _version_ | 1818545485631193088 |
|---|---|
| author | Yuqing Zhou Tingtao Chen |
| author_facet | Yuqing Zhou Tingtao Chen |
| author_sort | Yuqing Zhou |
| collection | DOAJ |
| description | Lung cancer is becoming one of the most detrimental cancers with the highest morbidity and mortality rate of all cancers, posing a significant burden for the global health system. Nonetheless, the therapeutic efficacy of traditional lung cancer therapies still remains relatively unsatisfying with varied responsiveness and unexpected adverse effects. Fortunately, studies have reported that an intimate relationship might exist between microbiota and lung carcinoma. Notably, microbial dysbiosis might result in changes in the metabolism, induction of immunosuppression, and recruitment of inflammatory factors, thereby driving lung carcinogenesis. Certain microbial strains were identified to be specifically enriched in the lung tumor beds, indicating their predictive role in lung cancer. Furthermore, the particular microbial composition was also proved to potentiate the outcomes of lung cancer therapies, suggesting that lung and gut microbiome were promising to be clinically applied for lung cancer therapy. In this review, we will comprehensively summarize the recent findings on how microbes mediate the initiation, progression, and treatment of lung cancer, illustrating the potential mechanisms and probing into the putative manipulation of microbiota to facilitate lung cancer treatments. |
| first_indexed | 2024-12-12T07:40:48Z |
| format | Article |
| id | doaj.art-ce9a4a0b546b434eba626274f9247cf8 |
| institution | Directory Open Access Journal |
| issn | 2590-0978 |
| language | English |
| last_indexed | 2024-12-12T07:40:48Z |
| publishDate | 2022-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Medicine in Microecology |
| spelling | doaj.art-ce9a4a0b546b434eba626274f9247cf82022-12-22T00:32:47ZengElsevierMedicine in Microecology2590-09782022-09-0113100055Human microbiota: A crucial gatekeeper in lung cancer initiation, progression, and treatmentYuqing Zhou0Tingtao Chen1Queen Mary School, Nanchang University, Nanchang, Jiangxi, 330031, ChinaNational Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330031, PR China; Corresponding author.Lung cancer is becoming one of the most detrimental cancers with the highest morbidity and mortality rate of all cancers, posing a significant burden for the global health system. Nonetheless, the therapeutic efficacy of traditional lung cancer therapies still remains relatively unsatisfying with varied responsiveness and unexpected adverse effects. Fortunately, studies have reported that an intimate relationship might exist between microbiota and lung carcinoma. Notably, microbial dysbiosis might result in changes in the metabolism, induction of immunosuppression, and recruitment of inflammatory factors, thereby driving lung carcinogenesis. Certain microbial strains were identified to be specifically enriched in the lung tumor beds, indicating their predictive role in lung cancer. Furthermore, the particular microbial composition was also proved to potentiate the outcomes of lung cancer therapies, suggesting that lung and gut microbiome were promising to be clinically applied for lung cancer therapy. In this review, we will comprehensively summarize the recent findings on how microbes mediate the initiation, progression, and treatment of lung cancer, illustrating the potential mechanisms and probing into the putative manipulation of microbiota to facilitate lung cancer treatments.http://www.sciencedirect.com/science/article/pii/S2590097822000052Lung cancerGut microbiotaLung microbiotaGut-lung axis |
| spellingShingle | Yuqing Zhou Tingtao Chen Human microbiota: A crucial gatekeeper in lung cancer initiation, progression, and treatment Medicine in Microecology Lung cancer Gut microbiota Lung microbiota Gut-lung axis |
| title | Human microbiota: A crucial gatekeeper in lung cancer initiation, progression, and treatment |
| title_full | Human microbiota: A crucial gatekeeper in lung cancer initiation, progression, and treatment |
| title_fullStr | Human microbiota: A crucial gatekeeper in lung cancer initiation, progression, and treatment |
| title_full_unstemmed | Human microbiota: A crucial gatekeeper in lung cancer initiation, progression, and treatment |
| title_short | Human microbiota: A crucial gatekeeper in lung cancer initiation, progression, and treatment |
| title_sort | human microbiota a crucial gatekeeper in lung cancer initiation progression and treatment |
| topic | Lung cancer Gut microbiota Lung microbiota Gut-lung axis |
| url | http://www.sciencedirect.com/science/article/pii/S2590097822000052 |
| work_keys_str_mv | AT yuqingzhou humanmicrobiotaacrucialgatekeeperinlungcancerinitiationprogressionandtreatment AT tingtaochen humanmicrobiotaacrucialgatekeeperinlungcancerinitiationprogressionandtreatment |